19-54252064-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001081442.3(LILRB5):c.1619T>C(p.Met540Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000167 in 1,613,930 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001081442.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LILRB5 | NM_001081442.3 | c.1619T>C | p.Met540Thr | missense_variant | Exon 12 of 13 | ENST00000449561.3 | NP_001074911.2 | |
LILRB5 | NM_001304457.3 | c.1592T>C | p.Met531Thr | missense_variant | Exon 12 of 13 | NP_001291386.2 | ||
LILRB5 | NM_006840.5 | c.1616T>C | p.Met539Thr | missense_variant | Exon 12 of 13 | NP_006831.2 | ||
LILRB5 | NM_001081443.3 | c.1319T>C | p.Met440Thr | missense_variant | Exon 11 of 12 | NP_001074912.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152132Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251382Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135860
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461680Hom.: 0 Cov.: 48 AF XY: 0.0000124 AC XY: 9AN XY: 727156
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152250Hom.: 0 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74444
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1619T>C (p.M540T) alteration is located in exon 12 (coding exon 12) of the LILRB5 gene. This alteration results from a T to C substitution at nucleotide position 1619, causing the methionine (M) at amino acid position 540 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at